Task: Answer the multiple-choice question.
Query: Which drug exhibits a -2.660\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1ccc(C)c(N(C(=O)c2csnn2)C(C(=O)NC2CCCC2)c2cccnc2)c1
b: Cc1cc(=O)[nH]c(SC(C(=O)O)c2ccccc2)n1
c: COc1ccc(OCCC(=O)NC2=NCCS2)cc1
Answer: c. COc1ccc(OCCC(=O)NC2=NCCS2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(OCCC(=O)NC2=NCCS2)cc1
COc1ccc(OCCC(=O)NC2=NCCS2)cc1
N-(4,5-dihydro-1,3-thiazol-2-yl)-3-(4-methoxyphenoxy)propanamide